In this white paper, “To SPA or Not to SPA: That is the Question. Understanding Special Protocol Assessments,” David Shoemaker, SVP of Research and Development at Rho, provides strategic recommendations for the effective use of SPAs as they relate to Phase 3 protocols.
Download this white paper to learn more about:
- Strategies for a successful SPA process
- Tips for optimal use of the SPA
- End of Phase 2 (EOP2) meetings as an alternative to the SPA